Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
03/30/2020 03/31/2020 04/01/2020 04/02/2020 04/03/2020 Date
133.01(c) 131.13(c) 128.81(c) 133.15(c) 134.17(c) Last
21 754 033 15 746 124 12 606 081 11 594 456 9 971 575 Volume
+8.00% -1.41% -1.77% +3.37% +0.77% Change
More quotes
Financials (USD)
Sales 2020 84 180 M
EBIT 2020 26 635 M
Net income 2020 19 338 M
Debt 2020 2 839 M
Yield 2020 3,00%
Sales 2021 89 211 M
EBIT 2021 29 351 M
Net income 2021 21 476 M
Finance 2021 1 484 M
Yield 2021 3,12%
P/E ratio 2020 18,6x
P/E ratio 2021 15,9x
EV / Sales2020 4,20x
EV / Sales2021 3,92x
Capitalization 351 B
More Financials
Company
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (51.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses,... 
Sector
Pharmaceuticals
Calendar
04/14 | 06:45amEarnings Release
More about the company
Surperformance© ratings of Johnson & Johnson
Trading Rating : Investor Rating :
More Ratings
Latest news on JOHNSON & JOHNSON
04:34pMACY'S, JOHNSON & JOHNSON, 3M : Stocks That Defined the Week
DJ
04/01JOHNSON & JOHNSON : Postpones 2020 Medical Devices Business Review Due to the Co..
PR
04/01LGT NAVIGATOR : Low visibility and high uncertainty
AQ
03/31JOHNSON & JOHNSON : to Host Virtual Annual Meeting of Shareholders
PR
03/31I HAVE NEVER SEEN A MOMENT SO RICH I : Johnson & Johnson Announces It Has Identi..
AQ
03/31JOHNSON & JOHNSON : identifies lead COVID-19 vaccine candidate
AQ
03/31JOHNSON & JOHNSON : Announces a Lead Vaccine Candidate for COVID-19 Landmark New..
AQ
03/31"I HAVE NEVER SEEN A MOMENT SO RICH : Johnson & Johnson Announces It Has Identi..
PU
03/31JOHNSON & JOHNSON : Announces a Lead Vaccine Candidate for COVID-19; Landmark Ne..
AQ
03/31JOHNSON & JOHNSON : Health boosts Wall St's rally
AQ
03/31JOHNSON & JOHNSON : J&J shares climb as it strikes $1bn US vaccine deal
AQ
03/30Abbott, Johnson & Johnson rise; SeaWorld, Carnival Fall
AQ
03/30Johnson & Johnson Up Over 8%, Best Performer in the DJIA So Far Today -- Data..
DJ
03/30JOHNSON & JOHNSON : IDs vaccine candidate, 2 backups for coronavirus
AQ
03/30JOHNSON & JOHNSON : to Begin Human Trials of Covid-19 Vaccine by September -- Up..
DJ
More news
News in other languages on JOHNSON & JOHNSON
04/01Un site bernois de J&J mis à contribution pour un vaccin expérimental anti-Co..
03/31CORONAVIRUS : essai clinique cet automne pour un vaccin de Johnson & Johnson
03/30Wall Street, saluant des mesures sanitaires, poursuit son rebond
03/30CORONAVIRUS : essai clinique cet automne pour un vaccin de Johnson & Johnson
03/30Wall Street débute la semaine dans le vert
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | MarketScreener
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 155,25  $
Last Close Price 133,15  $
Spread / Highest target 29,9%
Spread / Average Target 16,6%
Spread / Lowest Target -0,11%
EPS Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON-8.72%345 705
ROCHE HOLDING AG2.77%277 060
MERCK & CO., INC-16.16%195 141
NOVARTIS-12.10%187 703
PFIZER, INC.-14.14%181 075
NOVO NORDISK A/S5.61%141 503